Publication | Open Access

Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interaction

InflammationAnti-inflammatoryBiochemistryMedicineLipid PeroxidationImmunologyChronic InflammationCell DeathReceptor 4Lipopolysaccharide-induced Cardiomyocyte InjuryCardiovascular ToxicityPharmacologyOxidative Stress